Variant Bio Employee Directory
Biotechnology ResearchWashington, United States11-50 Employees
Variant Bio is a Seattle, Washington-based biotechnology company focused on drug discovery informed by human genetics. It studies the genes of people who are outliers for medically relevant traits to identify potential therapeutic targets and pathways. Through these insights, the company aims to contribute to therapies addressing global health needs, with collaborations to translate genetic findings into drug development opportunities. In January 2026, Variant Bio announced the launch of Inference, an AI-powered platform designed to accelerate genomic drug discovery from genetic data. The company also named Craig T. Basson as Chief Medical Officer and President of R&D, reflecting ongoing leadership development while it pursues collaborations with major pharmaceutical partners.